| (210) | Number of the EPO application | 17719409 |
| (220) | Filing date of the EPO application | 2017.04.04 |
| (80) | EPO patent specification publication (B) | EPB nr. 38/2023, 2023.09.20 |
| (110) | EPO patent number | 3439702 |
| (21) | Number of the application | e 2019 0191 |
| (71) | Name(s) of applicant(s), code of the country | Takeda Pharmaceutical Company Limited, JP; |
| (72) | Name(s) of inventor(s), code of the country | HOLMES Kevin, US;
NORTON Angela W., US;
PAN Clark, US; |
| (73) | Name(s) of owner(s), code of the country | Takeda Pharmaceutical Company Limited, JP; |
| (54) | Title of the invention | CONJUGATED C1 ESTERASE INHIBITOR AND USES THEREOF |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | A61K 47/60 (2017.01.01); A61K 47/61 (2017.01.01) |
| (19) | Country | JP |
| (41) | Date of publication of the application | 2019.03.31 |
| (30) | Priority | 201662318003 P, 2016.04.04, US |
| (86) | International application | PCT/US2017/026001, 2017.04.04 |
| (87) | International publication | WO 2017/176798, 2017.10.12 |